Lv11
100 积分 2022-03-27 加入
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
3小时前
已完结
Tolerance of standard dose albumin infused over 6 hrs for treatment of spontaneous bacterial peritonitis—A randomized controlled trial
1个月前
已完结
Albumin: a comprehensive review and practical guideline for clinical use
1个月前
已完结
Protein as a preoperative predictor – Impact of hypoalbuminemia on 30-day outcomes of breast reduction surgery
2个月前
已完结
Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients
2个月前
已完结
ALK-EML4 Fusion in Small Cell Lung Cancer: Clinical and Molecular Insights From a Rare Case
3个月前
已完结
A Case of Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion with Partial Response to Crizotinib
3个月前
已完结
Imaging Response to Ensartinib in Concurrent Papillary and Anaplastic Thyroid Carcinoma With ALK Rearrangement
4个月前
已关闭
Identification of a novel RSRC1-ALK (R6: A20) fusion using next-generation sequencing technique
6个月前
已完结
Comment on Frey et al A Real-World Pharmacovigilance Analysis of Lorlatinib-Associated Metabolic Effects Using the FDA Adverse Events Reporting System (FAERS) Database From 2013 to 2024
6个月前
已关闭
皖公网安备34019202002308
